| Entry |
|
|---|
| Name |
Endralazine (INN) |
|---|
| Formula |
C14H15N5O
|
|---|
| Exact mass |
269.1277
|
|---|
| Mol weight |
269.3018
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG02046 Hydrazinophthalazine derivative
|
|---|
| Remark |
|
|---|
| Efficacy |
Antihypertensive |
|---|
| Comment |
Hydrazinophthalazine derivative
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
C02DB Hydrazinophthalazine derivatives
C02DB03 Endralazine
D08254 Endralazine (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG02046 Hydrazinophthalazine derivative
DG00262 Endralazine
D08254 Endralazine
Drug groups [BR:br08330]
Cardiovascular agent
DG02046 Hydrazinophthalazine derivative
DG00262 Endralazine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 20
1 C8x C 20.3000 -18.3400
2 C8x C 20.3000 -19.7400
3 C8x C 21.4900 -20.4400
4 C8x C 22.7500 -19.7400
5 C8y C 22.7500 -18.3400
6 C8x C 21.4900 -17.6400
7 C1x C 25.1300 -19.7400
8 N1y N 25.1300 -18.3400
9 C5a C 23.9400 -17.6400
10 C1x C 26.3900 -20.4400
11 C8y C 27.5800 -19.7400
12 C8y C 27.5800 -18.3400
13 C1x C 26.3900 -17.6400
14 O5a O 23.9400 -16.2400
15 N5x N 28.7700 -20.4400
16 N4x N 29.9600 -19.7400
17 C8y C 29.9600 -18.3400
18 C8x C 28.7700 -17.6400
19 N2b N 31.2200 -17.6400
20 N1a N 32.4100 -18.3400
BOND 22
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 8 1
8 8 9 1
9 5 9 1
10 7 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 8 13 1
15 9 14 2
16 11 15 2
17 15 16 1
18 16 17 1
19 17 18 1
20 12 18 2
21 17 19 2
22 19 20 1
|
|---|
